764 related articles for article (PubMed ID: 37231000)
1. The blood-brain barrier: structure, regulation, and drug delivery.
Wu D; Chen Q; Chen X; Han F; Chen Z; Wang Y
Signal Transduct Target Ther; 2023 May; 8(1):217. PubMed ID: 37231000
[TBL] [Abstract][Full Text] [Related]
2. Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.
Zhang W
Handb Exp Pharmacol; 2024; 284():213-230. PubMed ID: 37528323
[TBL] [Abstract][Full Text] [Related]
3. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
4. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
Meng J; Agrahari V; Youm I
J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
[TBL] [Abstract][Full Text] [Related]
5. Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier.
Zha S; Liu H; Li H; Li H; Wong KL; All AH
ACS Nano; 2024 Jan; 18(3):1820-1845. PubMed ID: 38193927
[TBL] [Abstract][Full Text] [Related]
6. Experimental methods and transport models for drug delivery across the blood-brain barrier.
Fu BM
Curr Pharm Biotechnol; 2012 Jun; 13(7):1346-59. PubMed ID: 22201587
[TBL] [Abstract][Full Text] [Related]
7. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
8. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Zhou X; Smith QR; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
[TBL] [Abstract][Full Text] [Related]
9. Transport Across the Blood-Brain Barrier.
Fu BM
Adv Exp Med Biol; 2018; 1097():235-259. PubMed ID: 30315549
[TBL] [Abstract][Full Text] [Related]
10. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
11. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
Xie J; Shen Z; Anraku Y; Kataoka K; Chen X
Biomaterials; 2019 Dec; 224():119491. PubMed ID: 31546096
[TBL] [Abstract][Full Text] [Related]
12. Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.
Song J; Lu C; Leszek J; Zhang J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576281
[TBL] [Abstract][Full Text] [Related]
13. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
Al-Ahmady ZS
Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
[TBL] [Abstract][Full Text] [Related]
14. Getting drugs to the brain: advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood-brain barrier.
Tan Q; Zhao S; Xu T; Wang Q; Lan M; Yan L; Chen X
J Mater Chem B; 2022 Nov; 10(45):9314-9333. PubMed ID: 36349976
[TBL] [Abstract][Full Text] [Related]
15. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
16. CNS drug delivery systems: novel approaches.
Pathan SA; Iqbal Z; Zaidi SM; Talegaonkar S; Vohra D; Jain GK; Azeem A; Jain N; Lalani JR; Khar RK; Ahmad FJ
Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):71-89. PubMed ID: 19149731
[TBL] [Abstract][Full Text] [Related]
17. Advances in microphysiological blood-brain barrier (BBB) models towards drug delivery.
Lee CS; Leong KW
Curr Opin Biotechnol; 2020 Dec; 66():78-87. PubMed ID: 32711361
[TBL] [Abstract][Full Text] [Related]
18. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
Kristensen M; Brodin B
J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
[TBL] [Abstract][Full Text] [Related]
19. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
[TBL] [Abstract][Full Text] [Related]
20. Single domain antibody-based vectors in the delivery of biologics across the blood-brain barrier: a review.
Gao Y; Zhu J; Lu H
Drug Deliv Transl Res; 2021 Oct; 11(5):1818-1828. PubMed ID: 33155179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
